World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT02575001
Date of registration: 23/07/2015
Prospective Registration: No
Primary sponsor: University of Ljubljana, Faculty of Medicine
Public title: The Influence of Psychobiological Adversity to Children and Adolescents With Type 1 Diabetes
Scientific title: The Influence of Psychobiological Adversity to Children and Adolescents With Type 1 Diabetes
Date of first enrolment: July 2015
Target sample size: 207
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02575001
Study type:  Observational
Study design:   
Phase: 
Countries of recruitment
Slovenia
Contacts
Name:     Tadej Battelino, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  University of Ljubljana, Faculty of Medicine
Key inclusion & exclusion criteria

Inclusion Criteria:

- Informed consent signed by a parent/legal guardian and informed assent signed by the
study participant prior study entry

- Diagnosed with Type 1 DM prior to signature of Patient Informed Consent (PIC) (for the
T1D group).

- Age between 8-15 years old (inclusive) at signature of PIC

- Treated by the investigator's centre prior signature of PIC (For the T1D group).

- Willing to undergo all study procedures

Exclusion Criteria:

- Any documented concomitant chronic disease known to affect diabetes control (e.g.
altered renal function, active cancer undergoing treatment, Crohn's disease,
ulcerative colitis, Mb Addison disease)

- Any other medical, social or psychological condition that, in the investigator's
opinion, makes the patient unable to comply with the study protocol (e.g. intellectual
disability).



Age minimum: 8 Years
Age maximum: 15 Years
Gender: All
Health Condition(s) or Problem(s) studied
Stress
Type 1 Diabetes
Intervention(s)
Procedure: Saliva cortisol measurement
Procedure: Cortisol release test
Behavioral: Psychological background determinations
Genetic: Genetic susceptibility determination
Primary Outcome(s)
Significant between group differences in metabolic control [Time Frame: 1 month]
Secondary Outcome(s)
Significant differences in psychological scores between groups [Time Frame: 1 week]
Secondary ID(s)
Attachment2015
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history